The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma

被引:28
作者
Schmitz, Susanne [1 ]
Maguire, Aine [2 ,3 ]
Morris, James [4 ]
Ruggeri, Kai [3 ,14 ]
Haller, Elisa [5 ]
Kuhn, Isla [6 ]
Leahy, Joy [7 ]
Homer, Natalia [4 ]
Khan, Ayesha [8 ]
Bowden, Jack [9 ]
Buchanan, Vanessa [4 ]
O'Dwyer, Michael [10 ]
Cook, Gordon [11 ,12 ]
Walsh, Cathal [13 ]
机构
[1] Luxembourg Inst Hlth, Dept Populat Hlth, Strassen, Luxembourg
[2] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland
[3] Univ Cambridge, Dept Psychol, Cambridge, England
[4] Cogentia Healthcare Consulting, Cambridge, England
[5] Univ Zurich, Dept Psychol, Zurich, Switzerland
[6] Univ Cambridge, Univ Lib Med Lib, Cambridge, England
[7] Trinity Coll Dublin, Dept Comp Sci & Stat, Dublin, Ireland
[8] Univ Exeter, Exeter, Devon, England
[9] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[10] NUI Galway, Dept Med, Galway, Ireland
[11] St James Univ Hosp, Haematol & Myeloma Studies, Leeds, W Yorkshire, England
[12] St James Univ Hosp, NIHR MIC DEL, Leeds, W Yorkshire, England
[13] Univ Limerick, Hlth Res Inst, Limerick, Ireland
[14] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY USA
关键词
Network meta-analysis; Single armed studies; Evidence synthesis; Relapsed or refractory myeloma; LENALIDOMIDE PLUS DEXAMETHASONE; ADJUSTED INDIRECT COMPARISONS; MIXED TREATMENT COMPARISONS; LOW-DOSE DEXAMETHASONE; RANDOMIZED PHASE-III; PROPENSITY SCORE; REFRACTORY MYELOMA; TREATMENT OUTCOMES; BORTEZOMIB; THERAPY;
D O I
10.1186/s12874-018-0509-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of treatments that have not been studied in head-to-head trials; however, relative treatment effects for all interventions can only be derived where available evidence forms a connected network. Head-to-head evidence is limited in many disease areas, regularly resulting in disconnected evidence structures where a large number of treatments are available. This is also the case in the evidence of treatments for relapsed or refractory multiple myeloma. Methods: Randomised controlled trials (RCTs) identified in a systematic literature review form two disconnected evidence networks. Standard Bayesian NMA models are fitted to obtain estimates of relative effects within each network. Observational evidence was identified to fill the evidence gap. Single armed trials are matched to act as each other's control group based on a distance metric derived from covariate information. Uncertainty resulting from including this evidence is incorporated by analysing the space of possible matches. Results: Twenty five randomised controlled trials form two disconnected evidence networks; 12 single armed observational studies are considered for bridging between the networks. Five matches are selected to bridge between the networks. While significant variation in the ranking is observed, daratumumab in combination with dexamethasone and either lenalidomide or bortezomib, as well as triple therapy of carfilzomib, ixazomib and elozumatab, in combination with lenalidomide and dexamethasone, show the highest effects on progression free survival, on average. Conclusions: The analysis shows how observational data can be used to fill gaps in the existing networks of RCT evidence; allowing for the indirect comparison of a large number of treatments, which could not be compared otherwise. Additional uncertainty is accounted for by scenario analyses reducing the risk of over confidence in interpretation of results.
引用
收藏
页数:18
相关论文
共 50 条
[41]   Optimal daratumumab-based regimen for patients with newly diagnosed and previously untreated multiple myeloma: systematic review and component network meta-analysis [J].
Huang, Xiaohua ;
Zhou, Jia ;
Qian, Yuxiao ;
He, Jing ;
Yang, Lu ;
Wang, Zhigang ;
Wei, Diu ;
Li, Mengjie ;
Ma, Wei ;
Lang, Haiyan .
SYSTEMATIC REVIEWS, 2025, 14 (01)
[42]   Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis [J].
Blommestein, Hedwig M. ;
van Beurden-Tan, Chrissy H. Y. ;
Franken, Margreet G. ;
Uyl-de Groot, Carin A. ;
Sonneveld, Pieter ;
Zweegman, Sonja .
HAEMATOLOGICA, 2019, 104 (05) :1026-1035
[43]   Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta-analysis of randomized clinical trials [J].
Das, Avash ;
Dasgupta, Subhajit ;
Gong, Yan ;
Shah, Urvi A. ;
Fradley, Michael G. ;
Cheng, Richard K. ;
Roy, Bhaskar ;
Guha, Avirup .
HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) :233-242
[44]   Bayesian network meta-analysis methods for combining individual participant data and aggregate data from single arm trials and randomised controlled trials [J].
Janharpreet Singh ;
Sandro Gsteiger ;
Lorna Wheaton ;
Richard D. Riley ;
Keith R. Abrams ;
Clare L. Gillies ;
Sylwia Bujkiewicz .
BMC Medical Research Methodology, 22
[45]   Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis [J].
Mehta, Jayesh .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (20) :1430-1431
[46]   Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis [J].
Giralt, Sergio ;
Vesole, David H. ;
Somlo, George ;
Krishnan, Amrita ;
Stadtmauer, Edward ;
McCarthy, Philip ;
Pasquini, Marcelo C. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (13) :964-964
[47]   Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis [J].
Ramasamy, Karthik ;
Dhanasiri, Sujith ;
Thom, Howard ;
Buchanan, Vanessa ;
Robinson, Suzanne ;
D'Souza, Vijay K. ;
Weisel, Katja .
LEUKEMIA & LYMPHOMA, 2020, 61 (03) :668-679
[48]   Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis [J].
Thierry Facon ;
Jesús San-Miguel ;
Meletios A. Dimopoulos ;
Maria-Victoria Mateos ;
Michele Cavo ;
Sophie van Beekhuizen ;
Zijiao Yuan ;
João Mendes ;
Annette Lam ;
Jianming He ;
Eric Ammann ;
Shaji Kumar .
Advances in Therapy, 2022, 39 :1976-1992
[49]   Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART [J].
Kanters, Steve ;
Karim, Mohammad Ehsanul ;
Thorlund, Kristian ;
Anis, Aslam H. ;
Zoratti, Michael ;
Bansback, Nick .
BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
[50]   Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis [J].
Piechotta, Vanessa ;
Jakob, Tina ;
Langer, Peter ;
Monsef, Ina ;
Scheid, Christof ;
Estcourt, Lise J. ;
Ocheni, Sunday ;
Theurich, Sebastian ;
Kuhr, Kathrin ;
Scheckel, Benjamin ;
Adams, Anne ;
Skoetz, Nicole .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (11)